Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.
Hoedemaker NPG, Damman P, Ottervanger JP, Dambrink JHE, Gosselink ATM, Kedhi E, Kolkman E, de Winter RJ, van 't Hof AWJ. Hoedemaker NPG, et al. Among authors: gosselink atm. Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):127-138. doi: 10.1093/ehjcvp/pvy030. Eur Heart J Cardiovasc Pharmacother. 2019. PMID: 30084902
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.
van 't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, Gosselink AT, Zijlstra F, de Boer MJ. van 't Hof AW, et al. Eur Heart J. 2003 Aug;24(15):1401-5. doi: 10.1016/s0195-668x(03)00259-8. Eur Heart J. 2003. PMID: 12909068 Clinical Trial.
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure.
De Luca G, van 't Hof AW, de Boer MJ, Hoorntje JC, Gosselink AT, Dambrink JH, Ottervanger JP, Zijlstra F, Suryapranata H. De Luca G, et al. Circulation. 2004 Mar 2;109(8):958-61. doi: 10.1161/01.CIR.0000120504.31457.28. Epub 2004 Feb 23. Circulation. 2004. PMID: 14981008
Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: an angiographic risk score for use in the catheterization laboratory.
Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, Dambrink JH, Gosselink AT, van 't Hof AW, Hoorntje JC, Suryapranata H. Henriques JP, et al. Catheter Cardiovasc Interv. 2004 Mar;61(3):338-43. doi: 10.1002/ccd.10781. Catheter Cardiovasc Interv. 2004. PMID: 14988892
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Ernst NM, Suryapranata H, Miedema K, Slingerland RJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Zijlstra F, van 't Hof AW. Ernst NM, et al. J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93. doi: 10.1016/j.jacc.2004.06.050. J Am Coll Cardiol. 2004. PMID: 15364318 Free article. Clinical Trial.
127 results